Dolon Maji currently serves as a Senior Project Representative at AbbVie, specializing in Quantitative, Translational, and ADME (Absorption, Distribution, Metabolism, and Excretion) Sciences within the Biologics division. With a robust background in cancer research, Dolon is dedicated to advancing innovative therapies that address critical healthcare...
Dolon Maji currently serves as a Senior Project Representative at AbbVie, specializing in Quantitative, Translational, and ADME (Absorption, Distribution, Metabolism, and Excretion) Sciences within the Biologics division. With a robust background in cancer research, Dolon is dedicated to advancing innovative therapies that address critical healthcare challenges. His expertise in imaging science and fluorescence microscopy allows him to contribute significantly to the development of novel contrast agents and biologics that enhance diagnostic and therapeutic outcomes.
In his role, Dolon leads key projects that integrate cutting-edge methodologies in data analysis and cell biology. His proficiency in MATLAB and microscopy techniques enables him to design and execute complex experiments that yield valuable insights into cellular mechanisms and drug interactions. By collaborating with cross-functional teams, Dolon ensures that translational research is effectively aligned with clinical objectives, facilitating the seamless transition of promising therapies from the lab to the clinic.
Dolon’s commitment to leveraging scientific knowledge for breakthrough innovations is evident in his approach to problem-solving and project management. He actively engages in discussions around emerging trends in biotechnology, continuously seeking opportunities to enhance AbbVie's portfolio through strategic partnerships and innovative research initiatives. His passion for improving patient outcomes drives his work, making him a vital asset to AbbVie’s mission of transforming global healthcare.
